{"id":"placebo-tablet-or-capsule","safety":{"commonSideEffects":[{"rate":"20–40","effect":"Placebo effect (perceived symptom improvement)"},{"rate":"5–15","effect":"Nocebo effect (perceived adverse events)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebo formulations are inert preparations used as control comparators in clinical trials to distinguish the true pharmacological effects of an active drug from psychological and contextual healing responses. They rely on patient expectation, the therapeutic ritual, and natural disease progression or regression to produce measurable clinical outcomes. Placebos are essential tools in evidence-based medicine for establishing drug efficacy.","oneSentence":"A placebo tablet or capsule contains no active pharmaceutical ingredient and produces therapeutic effects solely through the placebo effect.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:36:13.684Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Clinical trial control arm (non-therapeutic use)"}]},"trialDetails":[{"nctId":"NCT06450366","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Enlicitide (MK-0616, Oral PCSK9 Inhibitor) Compared With Ezetimibe or Bempedoic Acid or Ezetimibe and Bempedoic Acid in Adults With Hypercholesterolemia (MK-0616-018/CORALreef AddOn)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-07-08","conditions":"Hypercholesterolemia","enrollment":301},{"nctId":"NCT06964776","phase":"PHASE1","title":"A Study of LY4268989 (MORF-057) in Healthy Participants","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2025-05-01","conditions":"Healthy","enrollment":144},{"nctId":"NCT05263206","phase":"PHASE3","title":"Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)","status":"RECRUITING","sponsor":"Sanofi","startDate":"2022-02-15","conditions":"Pruritus","enrollment":284},{"nctId":"NCT05421858","phase":"PHASE3","title":"A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis.","status":"RECRUITING","sponsor":"Basilea Pharmaceutica","startDate":"2024-12-11","conditions":"Candidemia, Candidiasis, Invasive","enrollment":450},{"nctId":"NCT05430152","phase":"PHASE2","title":"Low-dose Naltrexone for Post-COVID Fatigue Syndrome","status":"COMPLETED","sponsor":"Luis Nacul","startDate":"2024-01-15","conditions":"Post-Viral Fatigue Syndrome","enrollment":160},{"nctId":"NCT04191096","phase":"PHASE3","title":"Efficacy and Safety of Pembrolizumab (MK-3475) Plus Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus Enzalutamide Plus ADT in Participants With Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) (MK-3475-991/KEYNOTE-991)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2020-02-12","conditions":"Metastatic Hormone-Sensitive Prostate Cancer","enrollment":1251},{"nctId":"NCT06307652","phase":"PHASE3","title":"Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2024-04-12","conditions":"Heart Failure and Impaired Kidney Function","enrollment":4800},{"nctId":"NCT03748641","phase":"PHASE3","title":"A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2019-01-25","conditions":"Castration-Resistant Prostatic Cancer","enrollment":765},{"nctId":"NCT06231758","phase":"PHASE3","title":"Metformin Safety and Efficacy in Osteoarthritis.","status":"RECRUITING","sponsor":"Mostafa Bahaa","startDate":"2024-01-30","conditions":"Osteo Arthritis Knee","enrollment":70},{"nctId":"NCT07218549","phase":"PHASE1","title":"Evaluation of the Safety and Effects of Psychoactive Substances in People With Past Opioid Use","status":"NOT_YET_RECRUITING","sponsor":"Christopher D. Verrico","startDate":"2026-05-01","conditions":"Opioid Use, Substance Use Disorders, Opioid Analgesia","enrollment":72},{"nctId":"NCT07461402","phase":"NA","title":"Plant Protein With Ashwagandha-Rhodiola for Sleep Quality","status":"COMPLETED","sponsor":"Universidad Pablo de Olavide","startDate":"2025-11-01","conditions":"Sleep Quality, Sleep Disorders, Insomnia","enrollment":100},{"nctId":"NCT06671483","phase":"PHASE3","title":"A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines","status":"RECRUITING","sponsor":"Takeda","startDate":"2025-03-03","conditions":"Psoriatic Arthritis","enrollment":1088},{"nctId":"NCT04915183","phase":"PHASE2","title":"Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer","status":"RECRUITING","sponsor":"National Institute on Deafness and Other Communication Disorders (NIDCD)","startDate":"2024-07-10","conditions":"Hearing Loss, Head and Neck Cancer","enrollment":224},{"nctId":"NCT05986318","phase":"PHASE2","title":"Reducing Respiratory Symptoms of Pulmonary Irradiation in Interstitial Lung Disease","status":"RECRUITING","sponsor":"David Palma","startDate":"2025-01-07","conditions":"Lung Cancer, Interstitial Lung Disease","enrollment":98},{"nctId":"NCT07454408","phase":"PHASE1, PHASE2","title":"Evaluation of the Outcome of Fecal Microbiota Transplantation","status":"NOT_YET_RECRUITING","sponsor":"Air Force Military Medical University, China","startDate":"2026-03-07","conditions":"Hepatic Encephalopathy, Fecal Microbiota Transplantation, TIPS","enrollment":40},{"nctId":"NCT06566794","phase":"NA","title":"KF2022#4-trial: Effects of a Beta Blocker and NSAID on CYP Mediated Drug Metabolism","status":"COMPLETED","sponsor":"Helsinki University Central Hospital","startDate":"2024-08-22","conditions":"Drug Interaction","enrollment":12},{"nctId":"NCT04224493","phase":"PHASE3","title":"A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituximab Versus Placebo in Combination With Lenalidomide Plus Rituximab in Adult Patients at Least 18 Years of Age With Relapsed/Refractory Follicular Lymphoma.","status":"RECRUITING","sponsor":"Epizyme, Inc.","startDate":"2020-06-11","conditions":"Relapsed/Refractory Follicular Lymphoma, Follicular Lymphoma, Refractory Follicular Lymphoma","enrollment":612},{"nctId":"NCT03598309","phase":"PHASE2","title":"Phase II Trial to Modulate Intermediate Endpoint Biomarkers in Former and Current Smokers","status":"ACTIVE_NOT_RECRUITING","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2019-06-05","conditions":"Lung Diseases, Lung Cancer, Protection Against","enrollment":19},{"nctId":"NCT03016819","phase":"PHASE3","title":"Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)","status":"RECRUITING","sponsor":"Advenchen Laboratories, LLC","startDate":"2017-08-15","conditions":"Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma","enrollment":325},{"nctId":"NCT07421427","phase":"NA","title":"Adding Amantadine or Duloxetine to Pregabalin on Occurrence of Post Mastectomy Pain Syndrome","status":"RECRUITING","sponsor":"Cairo University","startDate":"2026-02-21","conditions":"Amantadine, Duloxetine, Pregabalin","enrollment":150},{"nctId":"NCT04926818","phase":"PHASE3","title":"Efficacy and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Pediatric Patients With Multiple Sclerosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2021-10-05","conditions":"Multiple Sclerosis (MS)","enrollment":129},{"nctId":"NCT07411482","phase":"NA","title":"The Effect of Probiotic Supplementation on the Exercise Performance of Long-distance Runners.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Medical University of Gdansk","startDate":"2023-12-01","conditions":"Intestinal Microbiome, Probiotic, Runners","enrollment":27},{"nctId":"NCT07408232","phase":"PHASE1, PHASE2","title":"A Phase 1/2 Study in Healthy Volunteers and Participants With Autosomal Dominant Retinitis Pigmentosa (RHO-adRP)","status":"RECRUITING","sponsor":"Octant, Inc.","startDate":"2026-02-09","conditions":"Retinitis Pigmentosa","enrollment":50},{"nctId":"NCT07407400","phase":"PHASE4","title":"Lemborexant for Sleep and Delirium Prevention in Elderly ICU Patients","status":"NOT_YET_RECRUITING","sponsor":"Mahidol University","startDate":"2026-04-01","conditions":"Sleep Disturbance, Delirium, Critical Illness","enrollment":100},{"nctId":"NCT07407634","phase":"EARLY_PHASE1","title":"A Randomized, Double-blind, Single-center Phase I/IIa Study of XTYW007 Tablets in Subjects.","status":"NOT_YET_RECRUITING","sponsor":"Xi'an Xintong Pharmaceutical Research Co.,Ltd.","startDate":"2026-03-25","conditions":"Non-Alcoholic Fatty Liver Disease","enrollment":94},{"nctId":"NCT04624243","phase":"PHASE2","title":"Efficacy and Safety of MK-8189 in Participants With an Acute Episode of Schizophrenia (MK-8189-008)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2020-12-15","conditions":"Schizophrenia","enrollment":499},{"nctId":"NCT04487080","phase":"PHASE3","title":"A Study of Amivantamab and Lazertinib Combination Therapy Versus Osimertinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2020-09-30","conditions":"Carcinoma, Non-Small-Cell Lung","enrollment":1074},{"nctId":"NCT06845124","phase":"PHASE2","title":"A Trial to Investigate the Effects of Cannabidiol Plus Naltrexone on Alcohol Craving in Patients With Alcohol Dependence","status":"RECRUITING","sponsor":"Central Institute of Mental Health, Mannheim","startDate":"2025-07-22","conditions":"Alcohol Addiction, Alcoholism","enrollment":150},{"nctId":"NCT03482479","phase":"PHASE2","title":"Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2019-02-04","conditions":"Eosinophilic Granulomatosis With Polyangiitis (EGPA), Churg-Strauss Syndrome (CSS), Giant Cell Arteritis","enrollment":60},{"nctId":"NCT03667326","phase":"PHASE2","title":"Postpartum Low-Dose Aspirin and Preeclampsia","status":"RECRUITING","sponsor":"Columbia University","startDate":"2019-07-22","conditions":"Preeclampsia Postpartum","enrollment":100},{"nctId":"NCT04679376","phase":"PHASE2","title":"Statins for the Treatment of NASH","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mayo Clinic","startDate":"2023-01-25","conditions":"NASH - Nonalcoholic Steatohepatitis","enrollment":70},{"nctId":"NCT04964934","phase":"PHASE3","title":"Phase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC With Detectable ESR1m Before Progression (SERENA-6)","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2021-06-30","conditions":"ER-Positive HER2-Negative Breast Cancer","enrollment":315},{"nctId":"NCT04516967","phase":"PHASE3","title":"Avatrombopag for the Treatment of Thrombocytopenia in Pediatric Subjects With Immune Thrombocytopenia for ≥6 Months","status":"COMPLETED","sponsor":"Sobi, Inc.","startDate":"2021-03-05","conditions":"Immune Thrombocytopenia","enrollment":75},{"nctId":"NCT01988883","phase":"EARLY_PHASE1","title":"Modafinil and Cognitive Function in POTS","status":"ACTIVE_NOT_RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2014-10","conditions":"Postural Tachycardia Syndrome","enrollment":20},{"nctId":"NCT06698926","phase":"PHASE1","title":"A Study to Assess the Safety, Tolerability, and Interactions of ABBV-CLS-616 Oral Tablets in Healthy Adult Participants","status":"COMPLETED","sponsor":"AbbVie","startDate":"2024-11-11","conditions":"Healthy Volunteer","enrollment":110},{"nctId":"NCT06967857","phase":"PHASE2","title":"Clinical Trial to Investigate the Safety and Efficacy of Two Dexamfetamine Sulfate Formulations in Adults With ADHD and Moderate to Severe Depression","status":"RECRUITING","sponsor":"Prof. Dr. Frank Behrens","startDate":"2025-05-15","conditions":"Attention-Deficit/Hyperactivity Disorder (ADHD), Depression - Major Depressive Disorder","enrollment":105},{"nctId":"NCT05056727","phase":"PHASE3","title":"A Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on Chronic Kidney Disease (CKD) Progression in Participants With CKD and Hyperkalaemia or at Risk of Hyperkalaemia","status":"TERMINATED","sponsor":"AstraZeneca","startDate":"2021-09-30","conditions":"Renal Insufficiency, Chronic, Hyperkalemia","enrollment":1112},{"nctId":"NCT03621553","phase":"PHASE4","title":"Vitamin D Homeostasis in Sarcoidosis","status":"RECRUITING","sponsor":"University of Texas Southwestern Medical Center","startDate":"2010-07-01","conditions":"Sarcoidosis, Vitamin D Insufficiency","enrollment":90},{"nctId":"NCT07303088","phase":"NA","title":"Effects of L-carnitine and Coenzyme Q10 Supplementation on Oxidative Stress in Tunisian Hemodialysis Patients.","status":"COMPLETED","sponsor":"University of Sfax","startDate":"2024-06-17","conditions":"Oxidative Stress Response, Hemodialysis, End Stage Kidney Disease (ESRD)","enrollment":52},{"nctId":"NCT05418049","phase":"PHASE2","title":"Evaluating the Neurophysiologic and Clinical Effects of Single Dose Drug Challenge","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2022-09-08","conditions":"Fragile X Syndrome","enrollment":45},{"nctId":"NCT06338553","phase":"EARLY_PHASE1","title":"GLP-1Ra Impact on Metabolic Outcomes in Stage 2 T1DM While Receiving Teplizumab","status":"RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2024-06-12","conditions":"Type 1 Diabetes","enrollment":24},{"nctId":"NCT06973291","phase":"PHASE3","title":"A Study Comparing Zasocitinib (TAK-279) With Deucravacitinib in Adults With Plaque Psoriasis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Takeda","startDate":"2025-07-09","conditions":"Plaque Psoriasis","enrollment":606},{"nctId":"NCT07135687","phase":"PHASE4","title":"Study to Use Oral Losartan to Decrease the Risk of Postoperative Scarring Following (ACL) Reconstruction","status":"NOT_YET_RECRUITING","sponsor":"Rush University Medical Center","startDate":"2026-08","conditions":"ACL Injury, ACL Reconstruction, Scar Formation","enrollment":144},{"nctId":"NCT07273799","phase":"PHASE3","title":"Comparison of Outcomes Between Topical Minoxidil Versus Oral Minoxidil for the Treatment of Androgenetic Alopecia","status":"NOT_YET_RECRUITING","sponsor":"Sheikh Zayed Federal Postgraduate Medical Institute","startDate":"2025-12-20","conditions":"Androgenic Alopecia","enrollment":200},{"nctId":"NCT03582176","phase":"PHASE3","title":"PrEvention of Posttraumatic Joint contractuRes With Ketotifen 2","status":"COMPLETED","sponsor":"University of Calgary","startDate":"2019-04-26","conditions":"Elbow Fracture, Elbow Injury, Elbow Dislocation","enrollment":395},{"nctId":"NCT06223685","phase":"NA","title":"The Efficacy of Probiotics as an Adjunct to Treatment of SIBO With Rifaximin","status":"COMPLETED","sponsor":"Pomeranian Medical University Szczecin","startDate":"2023-04-01","conditions":"Irritable Bowel Syndrome, Small Intestinal Bacterial Overgrowth, SIBO","enrollment":129},{"nctId":"NCT04940052","phase":"PHASE3","title":"Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Previously Treated Patients With Metastatic, Radio-active Iodine Refractory BRAF V600E Mutation Positive Differentiated Thyroid Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2021-11-15","conditions":"Differentiated Thyroid Cancer (DTC)","enrollment":153},{"nctId":"NCT06213818","phase":"PHASE1","title":"A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of INCB160058 When Administered Orally to Healthy Adult Participant","status":"COMPLETED","sponsor":"Incyte Corporation","startDate":"2024-03-14","conditions":"Healthy Participants","enrollment":137},{"nctId":"NCT04711252","phase":"PHASE3","title":"A Comparative Study of AZD9833 Plus Palbociclib Versus Anastrozole Plus Palbociclib in Patients With ER-Positive HER2 Negative Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2021-01-28","conditions":"ER-Positive HER2-Negative Breast Cancer","enrollment":1370},{"nctId":"NCT06005597","phase":"PHASE3","title":"Study of Obicetrapib & Ezetimibe Fixed Dose Combination on Top of Maximum Tolerated Lipid-Modifying Therapies","status":"COMPLETED","sponsor":"NewAmsterdam Pharma","startDate":"2024-03-01","conditions":"Dyslipidemias, Hypercholesterolemia, Familial Hypercholesterolemia","enrollment":407},{"nctId":"NCT07206901","phase":"NA","title":"Evaluation of an Ayurvedic Herbal Compound Compared to Vitamins C+E and Placebo on Vascular Function in High-Risk Subjects","status":"COMPLETED","sponsor":"Maharishi International University","startDate":"2002-10-14","conditions":"Coronary Artery Disease","enrollment":143},{"nctId":"NCT04934722","phase":"PHASE3","title":"Efficacy and Safety of Pembrolizumab (MK-3475) Plus Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus Enzalutamide Plus ADT in Participants With Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) (MK-3475-991/KEYNOTE-991)-China Extension","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2021-05-25","conditions":"Metastatic Hormone-Sensitive Prostate Cancer","enrollment":186},{"nctId":"NCT05743244","phase":"PHASE2","title":"Janus Kinase (JAK) Inhibitors to Preserve C-Peptide Production in New Onset Type 1 Diabetes (T1D)","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2023-10-19","conditions":"Diabetes Mellitus, Type 1","enrollment":78},{"nctId":"NCT02479204","phase":"PHASE1","title":"Clinical Study to Investigate Safety and Effects on Heart Rate, Blood Pressure, and Pharmacokinetic Interactions of ACT-334441","status":"TERMINATED","sponsor":"Viatris Innovation GmbH","startDate":"2015-04-28","conditions":"Healthy Subjects","enrollment":10},{"nctId":"NCT02967692","phase":"PHASE3","title":"A Study of the Anti-PD1 Antibody PDR001, in Combination With Dabrafenib and Trametinib in Advanced Melanoma","status":"TERMINATED","sponsor":"Novartis Pharmaceuticals","startDate":"2017-02-17","conditions":"Melanoma","enrollment":568},{"nctId":"NCT03971695","phase":"PHASE1","title":"A Study to Test How Well Healthy Men Tolerate Different Doses of BI 706321","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2019-06-18","conditions":"Healthy","enrollment":73},{"nctId":"NCT04037605","phase":"EARLY_PHASE1","title":"Hormonal Mechanisms of Sleep Restriction - Axis Study in Older Men and Postmenopausal Women","status":"ACTIVE_NOT_RECRUITING","sponsor":"Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center","startDate":"2020-02-09","conditions":"Sleep Restriction","enrollment":5},{"nctId":"NCT07037875","phase":"PHASE3","title":"A Study Comparing the Effect and Safety of Linaprazan Glurate to Lansoprazole in Participants With Erosive Esophagitis (EE) Due to Gastroesophageal Reflux Disease (GERD)","status":"NOT_YET_RECRUITING","sponsor":"Cinclus Pharma Holding AB","startDate":"2025-09","conditions":"GERD (Gastroesophageal Reflux Disease)","enrollment":500},{"nctId":"NCT04478266","phase":"PHASE3","title":"Amcenestrant (SAR439859) Plus Palbociclib as First Line Therapy for Patients With ER (+) HER2(-) Advanced Breast Cancer","status":"TERMINATED","sponsor":"Sanofi","startDate":"2020-10-14","conditions":"Breast Cancer","enrollment":1068},{"nctId":"NCT07146997","phase":"PHASE3","title":"Evaluating the Combined Effect of Oral Premedications on Inferior Alveolar Nerve Block Effectiveness","status":"COMPLETED","sponsor":"Zahoor khan","startDate":"2023-11-23","conditions":"Symptomatic Irreversible Pulpitis","enrollment":96},{"nctId":"NCT04085172","phase":"PHASE4","title":"A Study of TAK-503 in Children and Teenagers With Attention Deficit Hyperactivity Disorder (ADHD)","status":"COMPLETED","sponsor":"Shire","startDate":"2019-09-18","conditions":"Attention Deficit Hyperactivity Disorder","enrollment":396},{"nctId":"NCT02007512","phase":"PHASE2","title":"Efficacy and Safety Study of Enzalutamide in Combination With Exemestane in Patients With Advanced Breast Cancer","status":"COMPLETED","sponsor":"Pfizer","startDate":"2013-12-16","conditions":"Breast Cancer","enrollment":247},{"nctId":"NCT07078630","phase":"NA","title":"Modulation of hepcidIN With Co-supplementation of Iron and FORMulated Curcumin in Recreational Athletes","status":"COMPLETED","sponsor":"University of Westminster","startDate":"2023-10-05","conditions":"Iron Supplementation and Gastrointestinal Health, Iron Deficiency","enrollment":10},{"nctId":"NCT06861920","phase":"PHASE4","title":"NSAID Use for Treating Dysmenorrhea and Preventing Chronic Pelvic Pain (NSAID HEAL)","status":"RECRUITING","sponsor":"Endeavor Health","startDate":"2025-04-07","conditions":"Dysmenorrhea, Chronic Pelvic Pain, Pelvic Pain","enrollment":600},{"nctId":"NCT05957848","phase":"PHASE2","title":"Guanfacine Extended-release for Adolescents With Cannabis Use","status":"RECRUITING","sponsor":"Orygen","startDate":"2023-07-27","conditions":"Cannabis Use Disorder","enrollment":100},{"nctId":"NCT06597799","phase":"PHASE1","title":"First-in-human Study of MRT-6160 in Healthy Subjects","status":"COMPLETED","sponsor":"Monte Rosa Therapeutics, Inc","startDate":"2024-08-07","conditions":"Healthy Volunteers","enrollment":108},{"nctId":"NCT03834493","phase":"PHASE3","title":"Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2019-07-28","conditions":"Prostatic Neoplasms","enrollment":1244},{"nctId":"NCT04517864","phase":"PHASE2","title":"PLACEBO-CONTROLLED SAFETY STUDY OF RITLECITINIB (PF-06651600) IN ADULTS WITH ALOPECIA AREATA","status":"TERMINATED","sponsor":"Pfizer","startDate":"2020-09-15","conditions":"Alopecia Areata","enrollment":71},{"nctId":"NCT04960202","phase":"PHASE2, PHASE3","title":"EPIC-HR: Study of Oral PF-07321332/Ritonavir Compared With Placebo in Nonhospitalized High Risk Adults With COVID-19","status":"COMPLETED","sponsor":"Pfizer","startDate":"2021-07-16","conditions":"COVID-19","enrollment":2091},{"nctId":"NCT07047339","phase":"PHASE2, PHASE3","title":"Evaluate the Efficacy and Safety of Probiotic 6600 as an Adjuvant Therapy for Colitis","status":"RECRUITING","sponsor":"Changhai Hospital","startDate":"2025-07-01","conditions":"Colitis, IBD (Inflammatory Bowel Disease), Probiotic Intervention","enrollment":120},{"nctId":"NCT05713630","phase":"PHASE3","title":"The Use of Tranexamic Acid in the Treatment of Symptomatic Subdural Hematoma","status":"NOT_YET_RECRUITING","sponsor":"Unity Health Toronto","startDate":"2025-09-30","conditions":"Subdural Hematoma","enrollment":130},{"nctId":"NCT04996264","phase":"PHASE2","title":"Broad-spectrum Rapid Antidote: Varespladib Oral for Snakebite","status":"COMPLETED","sponsor":"Ophirex, Inc.","startDate":"2021-08-15","conditions":"Snakebites, Envenoming, Envenoming, Snake","enrollment":95},{"nctId":"NCT07042711","phase":"NA","title":"Impact of Vitamin D on Therapeutic Respons in NPC Chemoradiated Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Indonesia University","startDate":"2025-01-10","conditions":"Nasopharyngeal Cancinoma (NPC)","enrollment":300},{"nctId":"NCT06508983","phase":"PHASE3","title":"A Clinical Study Comparing SG301 Plus Pomalidomide and Dexamethasone to Placebo Plus Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma Patients","status":"RECRUITING","sponsor":"Hangzhou Sumgen Biotech Co., Ltd.","startDate":"2024-06-14","conditions":"Relapsed/Refractory Multiple Myeloma","enrollment":360},{"nctId":"NCT04129931","phase":"PHASE2","title":"PrecISE (Precision Interventions for Severe and/or Exacerbation-Prone Asthma) Network Study","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2019-12-19","conditions":"Asthma","enrollment":395},{"nctId":"NCT06517797","phase":"PHASE2","title":"One-Year Study of S1B-509 vs Placebo for Weight Loss","status":"NOT_YET_RECRUITING","sponsor":"S1 Biopharma, Inc.","startDate":"2025-10-15","conditions":"Obesity","enrollment":210},{"nctId":"NCT01692002","phase":"NA","title":"Oral Propionate to Treat and Prevent Diabetes","status":"TERMINATED","sponsor":"Imperial College London","startDate":"2013-01","conditions":"Diabetes Mellitus","enrollment":6},{"nctId":"NCT06636812","phase":"EARLY_PHASE1","title":"Losartan and Emotional Processing in Young People","status":"RECRUITING","sponsor":"University of Oxford","startDate":"2024-03-07","conditions":"Emotional Processing","enrollment":60},{"nctId":"NCT06350123","phase":"PHASE2","title":"Efficacy, Safety and Tolerability of Balcinrenone/Dapagliflozin Compared to Dapagliflozin in Adults With Chronic Kidney Disease","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2024-05-01","conditions":"Chronic Kidney Disease","enrollment":324},{"nctId":"NCT04984226","phase":"PHASE2","title":"Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD","status":"RECRUITING","sponsor":"University of California, Davis","startDate":"2023-09-08","conditions":"Chronic Kidney Diseases, Metabolic Acidosis, Fatigue","enrollment":80},{"nctId":"NCT05436652","phase":"PHASE2","title":"A Trial of Prednisolone in Combination With SPI-62 or Placebo in Subjects With Polymyalgia Rheumatica (PMR)","status":"COMPLETED","sponsor":"Sparrow Pharmaceuticals","startDate":"2022-07-22","conditions":"Polymyalgia Rheumatica","enrollment":66},{"nctId":"NCT05884866","phase":"PHASE2","title":"A Study to Investigate the Mechanistic Effects of Dapagliflozin Alone or in Combination With Balcinrenone, Compared to Balcinrenone and Placebo on Body Fluid and Electrolyte Handling and Energy Metabolism in Participants Over 50 Years of Age With Chronic Kidney Disease.","status":"RECRUITING","sponsor":"Klinikum Nürnberg","startDate":"2023-07-13","conditions":"Chronic Renal Failure, Mechanistic Effects of SGLT2 Inhibition and/ or MR Antagonism on Body Fluid and Electrolyte Homeostatis, Chronic Kidney Disease Stage 3","enrollment":100},{"nctId":"NCT05949008","phase":"PHASE4","title":"Effect of Metformin, a Drug Used to Treat Diabetes, vs Placebo","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of California, Los Angeles","startDate":"2023-11-22","conditions":"NIDDM, Obesity","enrollment":150},{"nctId":"NCT01701258","phase":"PHASE1","title":"An Investigation of Early Life Stress and Depression","status":"COMPLETED","sponsor":"Mclean Hospital","startDate":"2013-08","conditions":"Major Depressive Disorder (MDD), History of Childhood Sexual Abuse (CSA)","enrollment":153},{"nctId":"NCT05570305","phase":"PHASE2","title":"Zibotentan and Dapagliflozin in Patients With Type 2 Diabetes and Elevated Albuminuria","status":"COMPLETED","sponsor":"University Medical Center Groningen","startDate":"2022-10-06","conditions":"Chronic Kidney Diseases","enrollment":42},{"nctId":"NCT06622057","phase":"PHASE3","title":"D07001 Softgel-Capsules and Capecitabine Combination Therapy in Patients With Advanced Biliary Tract Cancer","status":"NOT_YET_RECRUITING","sponsor":"InnoPharmax Inc.","startDate":"2025-07-01","conditions":"Biliary Tract Cancer (BTC)","enrollment":195},{"nctId":"NCT03882255","phase":"PHASE1","title":"A Study of Ponesimod in Healthy Adult Participants Receiving Propranolol at Steady State","status":"COMPLETED","sponsor":"Janssen Pharmaceutica N.V., Belgium","startDate":"2019-03-20","conditions":"Healthy","enrollment":52},{"nctId":"NCT03740178","phase":"PHASE1","title":"Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005)","status":"WITHDRAWN","sponsor":"Merck Sharp & Dohme LLC","startDate":"2019-09-27","conditions":"Alzheimer's Disease, Mild Cognitive Impairment","enrollment":""},{"nctId":"NCT06828887","phase":"PHASE2","title":"Dose-Finding Clinical Trial to Evaluate the Efficacy and Safety of LV232 Capsules in the Treatment of MDD","status":"RECRUITING","sponsor":"Vigonvita Life Sciences","startDate":"2025-04-03","conditions":"MDD","enrollment":400},{"nctId":"NCT02330419","phase":"PHASE2","title":"Better Than Study: Targeting Heavy Alcohol Use With Naltrexone Among Men Who Have Sex With Men (MSM)","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2015-04","conditions":"Binge Drinking, HIV","enrollment":120},{"nctId":"NCT05742698","phase":"PHASE2","title":"Nabilone for Agitation in Frontotemporal Dementia","status":"RECRUITING","sponsor":"Simon Ducharme, MD","startDate":"2023-03-07","conditions":"Frontotemporal Dementia, Frontotemporal Dementia, Behavioral Variant, Primary Progressive Aphasia","enrollment":45},{"nctId":"NCT06878833","phase":"PHASE3","title":"A Study to Evaluate the Safety and Tolerability of Long-Acting Oral Risperidone (LYN-005) in Participants With Schizophrenia or Schizoaffective Disorder","status":"WITHDRAWN","sponsor":"Lyndra Inc.","startDate":"2025-04-18","conditions":"Schizophrenia, Schizoaffective Disorder","enrollment":""},{"nctId":"NCT04622293","phase":"PHASE4","title":"A Trial of Solriamfetol in the Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome","status":"COMPLETED","sponsor":"Rochester Center for Behavioral Medicine","startDate":"2021-04-27","conditions":"Chronic Fatigue Syndrome, Myalgic Encephalomyelitis","enrollment":44},{"nctId":"NCT05635227","phase":"NA","title":"Dexamethasone, Olanzapine, Hemodynamics, and Ventilation in Cardiac Surgery","status":"RECRUITING","sponsor":"Rigshospitalet, Denmark","startDate":"2022-11-10","conditions":"Coronary Artery Disease, Aortic Valve Disease","enrollment":1200},{"nctId":"NCT04225078","phase":"PHASE1","title":"A Study to Evaluate the Effects of Loperamide (JNJ-289679) on Electrocardiogram Intervals in Healthy Adult Participants","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2020-01-17","conditions":"Healthy Participants","enrollment":66},{"nctId":"NCT06891469","phase":"NA","title":"Effects of an Acute Dose of Caffeine on the Performance of CrossFit Athletes","status":"COMPLETED","sponsor":"Democritus University of Thrace","startDate":"2022-01-22","conditions":"Healthy, Young Adults, Athletic Performance","enrollment":12},{"nctId":"NCT06205381","phase":"PHASE1","title":"Assessment of the Safety, Tolerability and Pharmacokinetics of AV078 in Healthy Volunteers","status":"COMPLETED","sponsor":"Aeovian Pharmaceuticals, Inc.","startDate":"2024-01-31","conditions":"Healthy Participants","enrollment":89},{"nctId":"NCT04679389","phase":"PHASE2, PHASE3","title":"Acetazolamide Efficacy in Ataxia in PMM2-CDG","status":"TERMINATED","sponsor":"Mayo Clinic","startDate":"2021-03-17","conditions":"Pmm2-CDG, CDG1A","enrollment":25},{"nctId":"NCT06560879","phase":"PHASE2","title":"Effectiveness of Probiotics for the Prevention of Gastrointestinal Toxicity in Children with Leukemia","status":"ENROLLING_BY_INVITATION","sponsor":"National Institute of Pediatrics, Mexico","startDate":"2025-02-01","conditions":"Probiotics, Gastrointestinal Diseases, Precursor Cell Lymphoblastic Leukemia-Lymphoma","enrollment":120},{"nctId":"NCT01958021","phase":"PHASE3","title":"Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2013-12-17","conditions":"Advanced, Metastatic Breast Cancer","enrollment":668}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":87152,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Placebo"],"phase":"marketed","status":"active","brandName":"Placebo Tablet or Capsule","genericName":"Placebo Tablet or Capsule","companyName":"Debiopharm International SA","companyId":"debiopharm-international-sa","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Placebo tablets or capsules are used as a control intervention in clinical trials to compare the effects of other treatments. Placebo has been studied in various conditions, including obesity, diabetes, and chronic obstructive pulmonary disease, as part of trials examining the thermogenic properties of other substances.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}